Your browser doesn't support javascript.
loading
Acute kidney injury in peripheral blood haploidentical hematopoietic stem cell transplantation: should attract enough attention.
Liu, Yanping; Duan, Ziwen; Li, Fang; Zhang, Xiao; Chen, Ruize; Lu, Hua; Qian, Sixuan; Wu, Hanxin; Chen, Lijuan; Zhu, Yu; Zhu, Han; Miao, Kourong.
Affiliation
  • Liu Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Duan Z; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Li F; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Zhang X; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Chen R; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Lu H; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Qian S; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Wu H; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Chen L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Zhu Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Zhu H; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China. hanzhu_1988@qq.com.
  • Miao K; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China. kourongmiao@163.com.
Bone Marrow Transplant ; 57(9): 1448-1450, 2022 09.
Article de En | MEDLINE | ID: mdl-35672465

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation de cellules souches hématopoïétiques / Transplantation de cellules souches de sang périphérique / Atteinte rénale aigüe / Maladie du greffon contre l'hôte Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Bone Marrow Transplant Sujet du journal: TRANSPLANTE Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation de cellules souches hématopoïétiques / Transplantation de cellules souches de sang périphérique / Atteinte rénale aigüe / Maladie du greffon contre l'hôte Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Bone Marrow Transplant Sujet du journal: TRANSPLANTE Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni